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SEMINAL acrosin inhibitors are natural antagonists of the acrosomal proteinase "acrosin" 
important for the spermatozoon to penetrate the zona pellucida, the innermost layer 
surrounding the vitellin membrane of the egg. They have first been discovered by Haendle et 
al* 1) by their ability to inhibit pancreatic trypsins. Their presence has been demonstrated for 
many mammalian species like man/2) pig/ 3"" 6) guinea p i g / 3 ) bull/ 7) hamster/8) rat/ 9) 
rabbit/ 1 0) mouse*1) and others. During the last decade attempts have been made to isolate and 
purify these acid- and heat-stable, low molecular-weight proteinase inhibitors. Gassical methods 
for protein separation have been used as well as the modern technique of affinity 
chromatography on insoluble trypsin resin/ 1 1) 
The preparation of homogenous inhibitors is complicated by the occurrence of numerous 
isoinhibitors in one species and by the occurrence of multiple chromatographic forms. The 
isoinhibitors are natural mutants and gene products of different genes in a heterogeneous 
population. They differ by single amino acid substitutions in their amino acid sequence (Table 
1). The multiple chromatographic forms are generated during processing and handling of the 
seminal plasma, e.g. by proteolytic attack of the polypeptide chain by aminopeptidases/3) by 
acid hydrolysis of Asp-Pro peptide bonds*12) or amide groups/1 3) and by a natural and 
introduced microheterogeneity in the carbohydrate portion of inhibitors with glycoprotein 
nature/1 4) 
The amino acid compositions of several acrosin inhibitors from seminal plasma (and from 
spermatozoa) of man, boar and guinea pig are presented in Table 1. All natural protein-
constituent amino acids have been found. The total number of amino acids per unit of inhibitor 
molecule corresponds to about sixty residues. Thus, the molecular weight of these seminal 
inhibitors is about 6000-7500 with respect to their protein part. 
In contrast to the human seminal inhibitor*2) the boar inhibitor is a glycoprotein/3'6) 
Several multiple chromatographic forms of this glycoprotein have been separated by ion 
equilibrium chromatography on SE-Sephadex C-25 and by electrophoresis on cellulose acetate 
folio/ 6) Their amount and elution pattern varies with pretreatment of the seminal plasma. 
Each of the active boar inhibitors recovered after electrophoretic separation gave an amino acid 
composition identical with one of thè isoinhibitors A, Aj or B / 6 ) However, the total 
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O n 
Amino A c i d Boar isoinhibitors from plasmate) Boar spermatozoate) Guinea pig vesicles(b) Human plasma HUSI II 
A A i B d e f b ß G - l G - 2 
Aspartic acid 7 7 7 7 6 6 6 6 5 6 6 
Threonine 4 4 4 4 4 4 4 1 1 3 3 
Serine 5 5 5 5 5 6 5 2 3 4 4 
Glutamic acid 5 5 5 5 4 4 4 10 9 4 3 
Proline 3 3 3 3 2 3 2 5 4 5 5 
Glycine 5 5 5 5 5 5 5 6 5 6 5 
Alanine 2 2 2 2 0 1 0 1 1 1 1 
Valine 1 1 1 1 3 3 3 3 3 1 1 
Half-cystine 6 6 6 6 6 6 6 6 6 6 6 
Methionine 1 1 1 1 1 1 1 0 0 2 2 
Isoleucine 2 2 2 2 1 1 1 4 3 4 4 
Leucine 2 2 2 2 3 3 3 5 4 2 2 
Tyrosine 3 3 3 3 4 4 4 2 1 2 3 
Phenylalanine 5 5 5 5 3 4 3 0 0 1 1 
Lysine 5 4 6 4 4 5 5 1 2 3 3 
Histidine 3 3 3 3 3 3 3 2 2 - 3 2 2 
Arginine 5 6 6 5 4 4 4 6 6 4 5 
Tryptophan 1 1 1 (1) 0 0 0 0 0 0 0 
Total 65 65 67 65 58 63 59 60 5 5 - 5 6 56 56 
Carbohydrates + + + + ._ _ _ _ _ 
Molecular weight - 1 1 , 5 0 0 - 1 1 , 5 0 0 - 1 2 , 0 0 0 - 1 1 , 5 0 0 6687 7217 6815 6772 6275-6412 6186 6319 
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( c ) Schiessler et al., 1974, this volume. 
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T A B L E 2. C A R B O H Y D R A T E COMPOSITION OF BOAR SEMINAL PLASMA 
ISOINHIBITORSOO 
Isoinhibitors 
A A(c) A i B B(c) 
Fuco se 0.05 0.91 0.74 0.05 0.8600 
Mannose 1.84 1.67 2.92 1.83 1.29 
Galactose 1.98 2.96 5.92 1.55 1.38 
Glucose 4.14(d) 0.66 0.96 1.28 1.34 
Galactosamine 2.27 2.38 5.16 2.49 2.44 
Glucosamine 3.40 2.80 7.96 1.35 2.87 
Sialic acid 0.05 0.09(0 0.41 0.05 0.05 
Total 13-15 13 25 9-10 12-13 
(a)Calculated for total m.w. 11,000. 
(h)Detennined after HCl-methanolysis, acetylation, and silylation by gas chroma-
tography. 
( c) Other peak from SE-Sephadex separation of isoinhibitors. 
(d) Sample dialyzed for 60 hr against 251 of dest. water prior to carbohydrate 
determination. 
( e) Determined by cystein-H2S04 method according to Dische and Shettles. 
(^Determined by resorcinol method according to Svennerholm. 
carbohydrate content of the different chromatographic forms varied considerably (Table 2). 
The differences in the total number of monosaccharide units ranges from about ten to almost 
twenty-five residues per inhibitor molecule. This explains the discrepancies and multiple 
molecular weight forms of 7000 up to 13,000 m.w. of the boar seminal inhibitor separated by 
gel filtration in several laboratories/5*6) In addition the monosaccharide composition of 
individual forms presented in Table 2 is subject to change and indicates a microheterogeneity of 
the carbohydrate moieties. 
STRUCTURE OF SEMINAL ACROSIN INHIBITORS 
A. The Boar Seminal Plasma Inhibitor 
The amino acid sequence of the sixty-five residues of boar seminal plasma inhibitor A1 was 
determined/12) The inhibitor was subjected to performic acid oxidation and arginine-directed 
tryptic cleavage after citraconylation of the e-amino groups of the lysine residues. Five arginine 
peptides and the C-terminal peptide were separated and purified by gel filtration and ion 
equilibrium chromatography. The twenty-six-residue peptide was further degraded by two 
lysine-directed tryptic cleavages, as indicated in Fig. 1. All tryptic peptides were sequenced in 
an automatic Beckman sequencer by a modified dimethyl-auylamine/trifluoroacetic acid buffer 
program/12) All phenylthiohydantoins were identified by chemical ionization mass spectro-
metry using isobutane as reactant gas. This procedure allowed unequivocal assignment of all 
amides. 
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FIG. 1. The lineai amino acid sequence of the acrosin inhibitor A i from boar seminal plasma. 
The arrows indicate the peptides after arginine-directed tryptic cleavage. The break points mark 
additional cleavages after lysine-directed cleavages of peptide T-4. The broken lines indicate 
peptides from limited acid hydrolysis of the Asp-Pro bond and from unspecific tryptic 
cleavage at Trp 54. The peptides were ordered on the basis of overlap peptides from a 
thermolytic digest 
Particularly noteworthy is the sensitivity of the Asp 22—Pro 23 peptide bond to acid 
hydrolysis. Cleavage of this bond due to acidic pretreatment of the inhibitor was found to 
occur in àn extent of 5-10%, giving rise to two additional peptides as indicated in Fig. 1. An 
unspecific tryptic hydrolysis at tryptophan 54 was observed in a peptide not previously 
subjected to performic acid oxidation. 
The tryptic peptides were ordered in the linear sequence given in Fig. 1 on the basis of 
overlap peptides obtained from a thermolytic digest of the native seminal inhibitor. A detailed 
description of the structure determination will be published separately/12> 
Three disulfide containing peptides were isolated and purified to homogeneity from the 
thermolytic digest of the native seminal inhibitor. The combination of the half-cystines is based 
on the amino acid composition of the isolated peptides each containing a single disulfide bridge, 
on three cycles of Edman degradation, and on the amino acid composition of the peptide halves 
after performic acid oxidation. The disulfide bridges are formed by the half-cystine residues I 
and V (Residues 7 and 39), II and IV (Residues 17 and 36), and Iffand VI (Residues 25 and 
57). Thus, the polypeptide chain folds into a globular and compact covalent structure pictured 
in Fig. 2. Three disulfide bridged loops are formed which have been designated A, B and C. The 
chain folding is equal to that of the pancreatic secretory trypsin inhibitors/ 1 5 ' 1 6 ) A detailed 
discussion of the homologies between these structures is subject of the last subjection. 
Two carbohydrate moieties have been detected in the boar seminal inhibitor A x . Their 
probable attachment sites are indicated in Fig. 2. Their attachment through O-glycosidic 
linkages to Ser 12 and Ser 62 is based on the amino acid composition of the protein part after 
basic sodium borohydride induced ^-elimination, on the isolation of the carbohydrate 
containing tryptic arginine peptides T-3 and T-6, on the results of Edman degradation of 
peptide T-3, and on the degradation of peptide T-6 by aminopeptidase K and carboxypeptidase 
B/ 1 2> 1 4> 
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CHO 
boar seminal acrosin inhibitor 
FIG. 2. Schematic representation of the covalent structure of the boar seminal plasma acrosin 
inhibitor demonstrating the pairing of the disulfide bridges. The probable attachment sites of 
the carbohydrate chains are indicated by - C H O . The reactive site peptide bond is formed by 
the amino acids Arg 19-Gin 20 in the B-loop as indicated by *. 
B. The Guinea Pig Seminal Vesicles Inhibitor 
The ^terminal amino acid sequence of the acrosin inhibitor e 2 from guinea pig seminal 
vesicles and of a tryptic peptide from the C-loop of the inhibitor were sequenced by 
conventional methods using the "dansyl-technique"/17) The amides have not been assigned. 
The amino acid sequence was elucidated for the first twenty-four residues including the reactive 
site peptide bond Lys 19—Glx 20 and for a tryptic octapeptide aligned in the positions 49 
through 56 on the basis of its homology to the boar seminal inhibitor. The alignment is 
presented in Fig. 5. The homology between the inhibitors from boar seminal plasma and from 
guinea pig seminal vesicles is obvious from the alignment of the sequenced fragments and from 
the composition of the not yet sequenced C-terminal part of the tryptic peptide (Residues 25 
through 32). 
From the amino acid sequence data of these two seminal acrosin inhibitors we are tempted 
to assume that all low molecular-weight, acid- and heat-stable acrosin inhibitors secreted into 
the mammalian seminal plasma are members of the same family of inhibitor proteins. 
INHIBITORY PROPERTIES 
Association Constants 
The association constants of some of the seminal inhibitors with acrosin of the same species 
as well as with trypsin have been determined using the titration method^18) and are given in 
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T A B L E 3. ASSOCIATION C O N S T A N T S ( M / L ) - 1 
Inhibitor Source 
Enzymes 
Boar 
acrosin 
Human 
acrosin 
Bovine 
trypsin Reference 
Boar seminal plasma 
Isoinhibitor A 1.4 X 109 3.2 X 109 Tschesche et al, 1974<6> 
Guinea pig seminal vesc 
Acrosin-trypsiri-plasrrüri inhibitor 
Acrosin-trypsin inhibitor 
3.5 X 109 
5X 108 
Fink, 1970; Fritz et al., 1 9 7 0 < u « 1 7 > 
Fink, 1970; Fri tz et al, 1970<U'17> 
Human seminal plasma 
H U S I - I I 9X 10 1 0 SchiesslerefaJ., 1974<2> 
I , 1 1 1 1 1 1 
2 U 6 7 
Inhibitor [)ug] — 
FIG. 3. Titration curves of boar acrosin with the boar seminal acrosin inhibitor (*) and the 
pancreatic secretory trypsin inhibitors from sheep (•), pig (•), and dog (o). Preincubation time 
of enzyme and inhibitor: 30 min in 0.2 M triethanolamine/HCl-buffer, pH 7.8 at 25°C. 
Table 3. Hie values are in the 1 0 9 - 1 0 1 0 liters/moles range. The homology between the seminal 
acrosin inhibitors and the pancreatic trypsin inhibitors from dog, pig and sheep explains their 
cross inhibitory activity against boar acrosin*19 * (Fig. 3). The most effective inhibitor, 
however, is still the boar seminal inhibitor indicating a species specificity and close mutual 
relationships in the evolution of enzyme—inhibitor systems. 
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Reactive Sites 
The reactive site of the boar inhibitor was identified as the peptide bond Arg 19-Gln 20 by 
partial proteolytic cleavage of this particular bond at acid pH using boar acrosin and subsequent 
isolation of the two polypeptide chains.*6) On the basis of its homology to the boar inhibitor 
the reactive site of the guinea pig inhibitor is the bond Lys 19-Glx 20 (Fig. 5). Thus, the boar 
inhibitor is an Arg-type inhibitor*3*6) while the guinea pig inhibitor is of the Lys-type and 
susceptible to inactivation by acylation.*3) 
Partial Proteolysis 
The partial proteolytic cleavage of the reactive site peptide bond Arg 19-Gln 20 of the boar 
inhibitor by boar acrosin at pH 3.75 established a thermodynamic equilibrium with 76 + 2% 
virgin inhibitor (peptide bond intact) and 24 + 2% modified inhibitor (this bond hydro-
lyzed).<6> 
A constant of hydrolysis of Khyd = 0.33 was calculated. The same value for Kiiyd was 
determined by several laboratories for the partial proteolysis of the pancreatic secretory trypsin 
inhibitors by trypsin.*2 °> 2 1 ) 
Temporary Inhibition 
The reliberation of proteolytic activity from an enzyme inhibitor complex was designated 
temporary inhibition*22) and was first investigated on the pancreatic secretory trypsin 
inhibitors and trypsin.*13 »2 3 ~ 2 5 ) We have observed the same phenomenon for the system boar 
seminal inhibitor and pancreatic trypsin.*6) However, the system boar seminal inhibitor and 
boar acrosin was found to be more stable*6) (Fig. 4). Isolation of more highly purified boar 
acrosin with higher specific activity*26) enabled us to study the phenomenon more carefully. 
FIG. 4. Temporary inhibitory effect of the acrosin inhibitor from boar seminal plasma against 
boar acrosin and bovine pancreatic trypsin. Molar ratio at zero time: inhibitor trypsin = 1.5:1 
and inhibitor boar acrosin = 1.7:1; in 0.2 M triethanolarnin/HCl-buffer, pH 7.8 (0.02 M CaCli) 
at 25°C*(trypsin) and 22°C (acrosin), respectively. Residual inhibitory activity against trypsin 
( -o- ) ; tryptic activity reappeared ( - • - ) ; inhibitory activity against boar acrosin ( - A - ) . 
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The inhibition is not permanent but can be described by the term "pseudopermanent", since 
the inhibition remains unchanged either at a pH of 7.8 or 3.75 of incubation for at least 45 hr 
at room temperature but then drops depending on pH. This is in contrast to the 4—6 times 
higher specific activity of boar acrosin compared to porcine (or bovine) trypsin that leads to 
expect a more rapid inactivation. The much slower inactivation probably reflects the more 
stringent steric requirements of the larger enzyme acrosin (m.w. 38,000) to attack a rigid 
substrate like the inhibitor. Whether the phenomenon of inactivation of the seminal inhibitor 
by acrosin is of any physiological significance, e.g. during the process known as capacitation, at 
present remains unknown. 
HOMOLOGIES AND EVOLUTION 
A homology between the inhibitors from boar seminal plasma and from boar pancreatic 
juice is obvious from the alignment of both amino acid sequences (Fig. 5). Maximal homology 
is obtained only if three deletions are placed in the region of the A-loop of the pancreatic 
inhibitor l , ( 2 7 -29) e g ^ ^ positions 15, 17 and 18. The homology then is based on 
seventeen identical amino acid residues in corresponding positions and on a great number of 
conservative substitutions. Especially all half-cystine residues are in homologous positions. 
Thus, the B- and C-loop contain identical numbers of twenty and thirty-three amino acid 
residues, respectively, while the A-loop is extended by three residues. Since one of the 
carbohydrate moieties is attached to the A-loop, this loop obviously is oriented towards the 
surface of the molecule. Both carbohydrate chains are fairly apart from the reactive site 
obviously not interfering with the enzyme complex formation. From the absence of 
carbohydrates in the pancreatic inhibitor it is obvious that the sugar moieties are without 
significance for the inhibitory function. The same argument holds true for the eight C-terminal 
and the three N-terminal amino acid residues in the seminal inhibitor which by comparison to 
the pancreatic inhibitor I and the des—Thr—Ser—Glu—Pro—Arg-inhibitor I* 3 0* 3 1) are un-
important for the inhibitory activity. 
The boar seminal and the boar pancreatic inhibitor are products of the same ancestral gene 
that doubled during evolution and evolved independently. Both homologous inhibitors are 
secretory proteins, however, one is a glycoprotein, the other a plain protein. On this basis the 
argument that the carbohydrates are important structural elements to allow active transport 
through all membranes becomes somewhat arbitrary. This situation resembles the one of the 
cow colostrum inhibitor, which is a glycoprotein,*32>33) and the bovine trypsin-kallikrein 
inhibitor (Kunitz), which is a plain protein. However, the latter inhibitor is an intracellular 
component and not secreted from the tissue and thus the situation is not comparable. 
The comparison of the structure of the seminal inhibitors can be extended to non-
mammalian inhibitors as presented in Fig. 5. These proteinase inhibitors are altogether members 
of a single family of genetically related proteins of which the bovine pancreatic secretory 
trypsin inhibitor (Kazal's inhibitor)*34) was the first representative to be discovered. The 
structure of the boar and guinea pig seminal inhibitors is homologous to the human,*35) 
bovine,*36) porcine,* 2 7 - 2 9 ) and ovine pancreatic secretory inhibitors,*16*37) and to the two 
domains of the twice as long (doubled gene) dog submandibularis inhibitor*38) or the three 
domains of the three times larger (tripled gene) Japanese quail inhibitor,*39) or the already 
elaborated partial sequences of Bdellin B-3 from leeches.*40) All amino acid sequences have 
been aligned to give maximal homology. This implies that all half-cystines occupy correspond-
Boar seminal Thr Arg Lys Gin Pro Asn Cys _ _ _ _ _ Asn Val Tyr Arg Ser His Leu 
Guinea pig seminal Phe Ala Pro Ser Lys Val Asx Ser Cys _ _ _ _ _ Arg Pro Asx - Ser Asx -
Porcine pancreatic I Thr Ser Pro Gin Arg Glu Ala Thr Cys - - - - - Thr Ser Glu Val Ser - Gly 
Bovine pancreatic Asn Ile Leu Gly Arg Ghi Ala Lys Cys - - - - - Thr Asn Glu Val Asn - Gly 
Ovine pancreatic Asn Ile Leu Gly Arg Glu Ala Lys Cys - - - - - Thr Asn Glu Val Asn - Gly 
Human (Kazal) Asp Ser Leu Gly Arg Glu Ala Lys Cys - - - - - Tyr Asn Glu Leu Asn - Gly 
Dog submandibular- (I) Gly Pro Pro Pro Ala He Arg Gly Arg Glx Val Asx Cys - - - - - Ser Asx Tyr Lys Gly Lys Gly 
Dog submandibularis (II) Cys - - - - - Thr Glu Tyr - Asx Asx -
Japanese quail (I) Val Ghi Val Asp Cys Ser Arg Phe Pro Asn Thr Thr Asn Glu Glu - Gly 
Japanese quail (ID ,Val, Thr) Met Asp Cys Ser Arg Tyr Pro Asn Thr Thr Ser Glu Asp - Gly 
Japanese quail (HI) Val Ser Val Asp Cys Ser Glx Tyr Pro Lys Pro Ala - - - - - £ 
Bdellin B-3 Asp Thr Glu Cys - - - - - - - - - - - - > 
S 
Boar seminal - Phe Phe Cys Thr Arg Gin Met Asp - Pro He - Cys Gly Thr Asn Gly Lys Ser Tyr Ala Asn Pro Cys > 
Guinea pig seminal _ _ _ Arg) (MetCys Thr Lys) (Glx Leu Asx - Pro Val, - Cys, Gly, Thr, Asx, Gly, His, Thr, Tyr) E 
Porcine pancreatic I _ _ _ _ _ Cys Pro Lys Ile Tyr Asn - Pro Val - Cys Gly Thr Asp Gly He Thr Tyr Ser Asn Glu Cys > 
Bovine pancreatic - - - - - Cys Pro Arg He Tyr Asn - Pro Val - Cys Gly Thr Asp Gly Val Thr Tyr Ser Asn Glu Cys £j 
Ovine pancreatic _ _ _ _ _ Cys Pro Arg He Tyr Asn - Pro Val - Cys Gly Thr Asp Gly Val Thr Tyr Ala Asn Glu Cys gl 
Human (Kazal) - - - - - Cys Thr Lys He Tyr Asn - Pro Val - Cys Gly Thr Asp Gly Asp Thr Tyr Pro Asn Glu Cys § 
Dog submandibularis (I) - Ser Glu He Ala Cys Pro Arg Leu His Glx - Pro He - Cys Gly Thr Asp His Lys Thr Tyr Ser Asn Glx Cys g 
Dog submandibularis (II) - Thr - - - Cys Thr Met Asp Tyr Asx Arg Pro Leu Tyr Cys Gly Ser Asp Gly Lys Asn Tyr Ser Asn Lys Cys p 
Japanese quail (I) Lys Asp Glu Val Val Cys Pro Asp Glu Leu Arg - Leu lie - Cys Gly Thr Asp Gly Val Thr Tyr Asn His Glu Cys *o 
Japanese quail (II) Lys Val Thr He Leu Cys Thr Lys Asp Phe Ser - Phe Val - Cys Gly Thr Asp Gly Val Thr Tyr Asp Asn Glu Cys £ 
Japanese quail (III) _ _ _ _ _ cys Pro Lys Asp Tyr Arg - Pro Val - Cys Gly Ser Asp Asp Lys Thr Tyr Ser Asn Lys Cys eg 
Bdellin B-3 - - - - Val Cys Thr Lys Ghi Leu His - Arg Val - Cys Gly Ser Asp Gly Val Thr Tyr Asp Asn Glu Cys ^ 
> 
Boar seminal He Phe Cys Ser Glu Lys Gly Leu Arg Asn Gm Lys Phe Asp Phe Gly His Trp Gly His Cys Arg Glu Tyr Thr Ser Ala Arg Ser o 
Guinea pig seminal Phe Thr Phe Ser His Tyr Gly Arg g 
Porcine pancreatic I Val Leu Cys Ser Glu Asn Lys Lys Arg Gin Thr Pro Val Leu Ile Gin Lys Ser Gly Pro Cys KA 
Bovine pancreatic Leu Leu Cys Met Glu Asn Lys Ghi Arg Gin Thr Pro Val Leu He Gin Lys Ser Gly Pro Cys 5 
Ovine pancreatic Leu Leu Cys Met Glu Asn Lys Glu Arg Gin Thr Pro Val Leu Ile Gin Lys Ser Gly Pro Cys a 
Human (Kazal) Val Leu Cys Phe Glu Asn Arg Lys Arg Gin Thr Ser He Leu Ile Gin Lys Ser Gly Pro Cys £ 
Dog submandibularis (I) Met Leu Cys Ala Phe Thr Leu Asp Lys Lys Phe Glx Val Arg Lys Leu Gin Asp Thr Ala Cys Asp He Glu 3 
Dog submandibularis (II) Ser Phe Cys Asn Ala Val Lys Ser Arg Gly Thr He Phe ? Leu Ala Lys His Gly Glu Cys 3 
Japanese quail (I) Met Leu Cys Phe Tyr Asn Lys Glu Tyr Gly Thr Asn He Ser Lys Glu Gin Asp Gly Glu Cys Gly (Glu,Pro,... O 
Japanese quail (II) Met Leu Cys Ala His Asn Val Val Gin Gly Thr Ser Val Gly Lys Lys His Asp Gly Glu Cys Arg Lys Glu Leu Ala Ala £ 
Japanese quail (III) Asn Phe Cys Asn Ala Val Val Glu Ser Asn Gly Thr Leu Thr Leu Asn His Phe Gly Lys Cys 
Bdellin B-3 
FIG. 5. Alignment of the homologous amino acid sequences of the boar seminal plasma acrosin 
inhibitor (top line)( 1 2) and the partial sequence of the guinea pig seminal vesicles inhibitor( 1 7) 
with the sequences of the porc ine / 2 7 -" 2 9 ) bovine,( 3 6) o v i n e O 6 » 3 7 ) and human( 3 5) pancreatic 
secretory trypsin inhibitor, and with the two domains of the dog submandibularis inhibitor/ 3 8 ) 
the three domains of the Japanese quail inhibitor/ 3 9 ) and the partial sequence of Bdellin B-3 
from leeches/ 4 0) u> 
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T A B L E 4. RING SIZE VARIATION O F T H E 
A-LOOPS IN T H E FAMILY O F K A Z A L - T Y P E 
INHIBITORS 
Inhibitor 
Number of 
A-loop residues 
Japanese Quail I 
Japanese Quail II 
Japanese Quail III 
Boar Seminal 
Guinea pig Seminal 
Pancreatic 
Dog Submandibularis I 
Dog Submandibularis II 
Bdellin B-3 
18 
18 
9 
11 
8 
13 
8 
1 
ing positions and that a varying number of deletions had to be placed between the first and the 
second disulfide bridge forming the A4oop. The A4oop presents a surprisingly variable region in 
all inhibitors. This explains why the homology between the boar seminal and the boar 
pancreatic inhibitor was not obvious from the amino acid sequence of the first twenty 
N-terminal residues.*6*41) The number of amino acid residues forming the A4oop varies from 
eighteen in the two domains of the Japanese quail inhibitor over eleven in the boar and nine in 
the guinea pig seminal inhibitor down to just one residue in the Bdellin B-3 sequence. The 
variations in the ring size of the A-loops have been documented in Table 4. Hie data favor the 
hypothesis that except for the hydrophobic residue P 4 preceding the second half-cystine bridge 
this A-loop is unimportant for maintaining the proper confirmation and the inhibitory activity. 
In contrast to the residue and ring size variation in the A-loop a strict preservation of the sizes of 
the B- and C-loops is striking. Thus, the B- and C-loops are the key structural elements of this 
family of proteinase inhibitors. 
The homology between the seminal and the pancreatic inhibitors documents an ancestral 
genetic relationship. This conclusion and the observation that biological systems like the 
acrosin—acrosin inhibitor or the trypsin—pancreatic trypsin inhibitor system evolve in mutual 
relationship allows us to anticipate that acrosin is an enzyme structurally closely related to 
trypsin. 
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